 | This biographical article is written like a résumé. (January 2022) |
Janet Woodcock | |
|---|---|
.png) | |
| Principal Deputy Commissioner of Food and Drugs | |
| In office February 18, 2022 – February 1, 2024 | |
| President | Joe Biden |
| Preceded by | Amy Abernethy |
| Succeeded by | Namandjé Bumpus |
| Commissioner of Food and Drugs | |
Acting | |
| In office January 20, 2021 – February 17, 2022 | |
| President | Joe Biden |
| Preceded by | Stephen Hahn |
| Succeeded by | Robert Califf |
| Director of the Center for Drug Evaluation and Research | |
| In office October 1, 2007 – April 12, 2021 Acting: October 1, 2007 – April 1, 2008 | |
| Preceded by | Steven K. Galson |
| Succeeded by | Patrizia Cavazzoni |
| In office May 1994 – April 2004 | |
| Preceded by | Carl Peck |
| Succeeded by | Steven K. Galson |
| Personal details | |
| Born | August 29, 1948 Washington, Pennsylvania, U.S. |
| Spouse | Roger Miller[1] |
| Education | Bucknell University (BS) Northwestern University (MD) |
| Awards | Biotechnology Heritage Award (2019) |
Janet Woodcock (born August 29, 1948) is an American physician who served as Principal Deputy Commissioner of Food and Drugs from February 2022 until February 2024, having previously served as Acting Commissioner of the U.S. Food and Drug Administration (FDA).[2] She joined the FDA in 1986, and has held a number of senior leadership positions there, including terms as the Director of Center for Drug Evaluation and Research (CDER) from 1994 to 2004 and 2007 to 2021.[3]
Woodcock has overseen the modernization and streamlining of CDER and FDA, introducing new initiatives to improve the timeliness and transparency of FDA procedures, and the safety, quality and effectiveness of drugs. She informs the United States Congress and other government bodies about the FDA and its concerns, helping to develop policy recommendations and legislation. In 2015, Woodcock received a Lifetime Achievement Award from the Institute for Safe Medication Practices in recognition of “a significant career history of making ongoing contributions to patient safety.”[4] She has also received the 2019 Biotechnology Heritage Award.[5]
- ^ Javers, Eamon (Mar 31, 2010). "Drug firm investigated FDA officials". Pittsburgh Post-Gazette. Retrieved 6 March 2019.
- ^ "FDA Alumni Association". U.S. Food and Drug Administration AlumnI Association. June 2, 2022.
- ^ "Janet Woodcock". The National Academies of Sciences, Engineering and Medicine. Archived from the original on 6 March 2019. Retrieved 5 March 2019.
- ^ Cite error: The named reference
Lifetimewas invoked but never defined (see the help page). - ^ Cite error: The named reference
Science History Institutewas invoked but never defined (see the help page).